Editorial: Epigenetic mechanisms and epigenetic-based therapies in cardiometabolic and vascular disease.
2024-03-30
Frontiers in genetics
J
14
1233096
1664-8021
abdominal aort aneurysm; cardiometabolic and vascular disease; epigenectic regulation; epigenetic therapeutics; noncoding RNA
Pre One:The Effect of N6-Methyladenosine Regulators and m6A Reader YTHDC1-Mediated N6-Methyladenosine Modification Is Involved in Oxidative Stress in Human Aortic Dissection.
Next One:Clinical symbiosis of hybrid nanoparticles and induced magnetic field on heat and mass transfer in multiple stenosed artery with erratic thrombosis